207 related articles for article (PubMed ID: 34185676)
1. Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer Phenotypes.
Apostolidi M; Vathiotis IA; Muthusamy V; Gaule P; Gassaway BM; Rimm DL; Rinehart J
Cancer Res; 2021 Aug; 81(16):4346-4359. PubMed ID: 34185676
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer.
Rajput S; Khera N; Guo Z; Hoog J; Li S; Ma CX
Oncotarget; 2016 Aug; 7(35):56864-56875. PubMed ID: 27486754
[TBL] [Abstract][Full Text] [Related]
3. Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.
Giannoni E; Taddei ML; Morandi A; Comito G; Calvani M; Bianchini F; Richichi B; Raugei G; Wong N; Tang D; Chiarugi P
Oncotarget; 2015 Sep; 6(27):24061-74. PubMed ID: 26183399
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of Pyruvate Kinase M Inhibits Cell Growth and Migration by Reducing NF-kB Activity in Triple-Negative Breast Cancer Cells.
Ma C; Zu X; Liu K; Bode AM; Dong Z; Liu Z; Kim DJ
Mol Cells; 2019 Sep; 42(9):628-636. PubMed ID: 31564074
[TBL] [Abstract][Full Text] [Related]
5. PKM2 Thr454 phosphorylation increases its nuclear translocation and promotes xenograft tumor growth in A549 human lung cancer cells.
Yu Z; Huang L; Qiao P; Jiang A; Wang L; Yang T; Tang S; Zhang W; Ren C
Biochem Biophys Res Commun; 2016 May; 473(4):953-958. PubMed ID: 27045080
[TBL] [Abstract][Full Text] [Related]
6. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
[TBL] [Abstract][Full Text] [Related]
7. PK-M2-mediated metabolic changes in breast cancer cells induced by ionizing radiation.
Zhang L; Bailleul J; Yazal T; Dong K; Sung D; Dao A; Gosa L; Nathanson D; Bhat K; Duhachek-Muggy S; Alli C; Dratver MB; Pajonk F; Vlashi E
Breast Cancer Res Treat; 2019 Nov; 178(1):75-86. PubMed ID: 31372790
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological Activation of Pyruvate Kinase M2 Inhibits CD4
Angiari S; Runtsch MC; Sutton CE; Palsson-McDermott EM; Kelly B; Rana N; Kane H; Papadopoulou G; Pearce EL; Mills KHG; O'Neill LAJ
Cell Metab; 2020 Feb; 31(2):391-405.e8. PubMed ID: 31761564
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic Kinase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-like Cells.
Zhou Z; Li M; Zhang L; Zhao H; Şahin Ö; Chen J; Zhao JJ; Songyang Z; Yu D
Cancer Res; 2018 May; 78(9):2248-2261. PubMed ID: 29440169
[TBL] [Abstract][Full Text] [Related]
10. Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer.
Dong T; Kang X; Liu Z; Zhao S; Ma W; Xuan Q; Liu H; Wang Z; Zhang Q
Tumour Biol; 2016 Jun; 37(6):8159-68. PubMed ID: 26715276
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin Superfamily Containing Leucine-Rich Repeat (ISLR) Serves as a Redox Sensor That Modulates Antioxidant Capacity by Suppressing Pyruvate Kinase Isozyme M2 Activity.
Wang T; Chen M; Su Y; Zhang Y; Liu C; Lan M; Li L; Liu F; Li N; Yu Y; Xiong L; Wang K; Liu J; Xu Q; Hu Y; Jia Y; Cao Y; Pan J; Meng Q
Cells; 2024 May; 13(10):. PubMed ID: 38786060
[TBL] [Abstract][Full Text] [Related]
12. Oleanolic acid suppresses aerobic glycolysis in cancer cells by switching pyruvate kinase type M isoforms.
Liu J; Wu N; Ma L; Liu M; Liu G; Zhang Y; Lin X
PLoS One; 2014; 9(3):e91606. PubMed ID: 24626155
[TBL] [Abstract][Full Text] [Related]
13. Interaction with Pyruvate Kinase M2 Destabilizes Tristetraprolin by Proteasome Degradation and Regulates Cell Proliferation in Breast Cancer.
Huang L; Yu Z; Zhang Z; Ma W; Song S; Huang G
Sci Rep; 2016 Mar; 6():22449. PubMed ID: 26926077
[TBL] [Abstract][Full Text] [Related]
14. Metabolic changes in triple negative breast cancer-focus on aerobic glycolysis.
Arundhathi JRD; Mathur SR; Gogia A; Deo SVS; Mohapatra P; Prasad CP
Mol Biol Rep; 2021 May; 48(5):4733-4745. PubMed ID: 34047880
[TBL] [Abstract][Full Text] [Related]
15. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
Woodcock CC; Huang Y; Woodcock SR; Salvatore SR; Singh B; Golin-Bisello F; Davidson NE; Neumann CA; Freeman BA; Wendell SG
J Biol Chem; 2018 Jan; 293(4):1120-1137. PubMed ID: 29158255
[TBL] [Abstract][Full Text] [Related]
16. Combination Treatment Using Pyruvate Kinase M2 Inhibitors for the Sensitization of High Density Triple-negative Breast Cancer Cells.
Lee JS; Oh Y; Lee JS; Park JH; Shin JK; Han JH; Kim HS; Yoon S
In Vivo; 2022; 36(5):2105-2115. PubMed ID: 36099094
[TBL] [Abstract][Full Text] [Related]
17. Pyruvate kinase M knockdown-induced signaling via AMP-activated protein kinase promotes mitochondrial biogenesis, autophagy, and cancer cell survival.
Prakasam G; Singh RK; Iqbal MA; Saini SK; Tiku AB; Bamezai RNK
J Biol Chem; 2017 Sep; 292(37):15561-15576. PubMed ID: 28778925
[TBL] [Abstract][Full Text] [Related]
18. PKM2, cancer metabolism, and the road ahead.
Dayton TL; Jacks T; Vander Heiden MG
EMBO Rep; 2016 Dec; 17(12):1721-1730. PubMed ID: 27856534
[TBL] [Abstract][Full Text] [Related]
19. [Novel mechanism for invasion and metastasis involving metabolic enzymes in intractable cancer cells].
Konno M; Hamabe A; Doki Y; Mori M; Ishii H
Rinsho Ketsueki; 2015 Aug; 56(8):1059-63. PubMed ID: 26345567
[TBL] [Abstract][Full Text] [Related]
20. C-MET-dependent signal transduction mediates retinoblastoma growth by regulating PKM2 nuclear translocation.
Dai H; Zeng W; Luo H
Cell Biochem Funct; 2020 Mar; 38(2):204-212. PubMed ID: 31729060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
